Yüklüyor......
Optimal first-line and second-line treatments for metastatic renal cell carcinoma: current evidence
Since 2005, an abundance of targeted agents has been approved for the treatment of metastatic renal cell carcinoma (mRCC), without any specification as to what may be the most optimal first-line and second-line sequence. Hence, our objective was to critically examine the evidence supporting the use...
Kaydedildi:
| Yayımlandı: | Int J Nephrol Renovasc Dis |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4219683/ https://ncbi.nlm.nih.gov/pubmed/25378943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S48496 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|